Zymeworks (ZYME) Cash & Current Investments (2021 - 2026)

Zymeworks (ZYME) has 6 years of Cash & Current Investments data on file, last reported at $364.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 37.48% year-over-year to $364.7 million; the trailing twelve-month figure through Mar 2026 stood at $364.7 million (up 37.48% YoY), and the FY2025 full-year result was $228.8 million, up 1.34% from the prior year.
• Cash & Current Investments improved to $364.7 million in Q1 2026, from $228.8 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $492.2 million in Q4 2022 to a low of $166.2 million in Q3 2022.
• A 5-year average of $306.6 million and a median of $297.2 million in 2024 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments jumped 94.86% in 2022 and slumped 39.68% in 2024, its largest moves.
• Tracing ZYME's Cash & Current Investments over 5 years: stood at $492.2 million in 2022, then declined by 23.95% to $374.3 million in 2023, then tumbled by 39.68% to $225.8 million in 2024, then gained by 1.34% to $228.8 million in 2025, then jumped by 59.41% to $364.7 million in 2026.
• Business Quant data shows ZYME's Cash & Current Investments at $364.7 million in Q1 2026, $228.8 million in Q4 2025, and $251.9 million in Q3 2025.